Idelalisib-mediated PI3Kδ inhibition for optimized generation of CD19-specific chimeric antigen receptor T cells

被引：0

作者：

Stock, Sophia ^{[1
]}

Schubert, Maria-Luisa ^{[1
]}

Hoffmann, Jean-Marc ^{[1
]}

Wang, Lei ^{[1
]}

Gong, Wenjie ^{[1
]}

Neuber, Brigitte ^{[1
]}

Hueckelhoven, Angela ^{[1
]}

Gern, Ulrike ^{[1
]}

Schmitt, Anita ^{[1
]}

Mueller-Tidow, Carsten ^{[1
,2
]}

Dreger, Peter ^{[1
,2
]}

Schmitt, Michael ^{[1
,2
]}

Sellner, Leopold ^{[1
,2
]}

机构：

[1] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany

[2] German Canc Consortium DKTK, Heidelberg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O141

引用

页码：119 / 120

页数：2

共 50 条

[21] Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells
Chen, Xiaojuan
Wang, Ying
Ruan, Min
Li, Jun
Zhong, Mengjun
Li, Zhanqi
Liu, Fang
Wang, Shuchun
Chen, Yumei
Liu, Lipeng
Yang, Jun J.
Zhu, Xiaofan
Wang, Jianxiang
Pui, Ching-Hon
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (06): : 366 - 370
[22] Design of a CD19-specific chimeric antigen receptor based on a monoclonal antibody LT19
Chikaev, Anton
Belovezhets, Tatyana
Kulemzin, Sergey
Filatov, Alexander
Gorchakov, Andrey
Taranin, Alexander
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 391 - 391
[23] Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
Diaconu, Iulia
Ballard, Brandon
Zhang, Ming
Chen, Yuhui
West, John
Dotti, Gianpietro
Savoldols, Barbara
MOLECULAR THERAPY, 2017, 25 (03) : 580 - 592
[24] Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition
Turtle, Cameron J.
Sommermeyer, Daniel
Berger, Carolina
Hudecek, Michael
Shank, David M.
Steevens, Natalia N.
Budiarto, Tanya M.
Karimi, Mandana
Chaney, Colette N.
DeVito, Anna Marie
Heimfeld, Shelly
Jensen, Michael C.
Riddell, Stanley R.
Maloney, David G.
BLOOD, 2014, 124 (21)
[25] Artificial antigen presenting cell can be used to propagate genetically modified CD19-specific T cells through chimeric antigen receptor.
Numbenjapon, T
Serrano, LMA
Olivares, S
Chang, WC
Singh, H
Kowolik, CM
Gonzalez, S
Gonzalez, N
Cooper, LJN
BLOOD, 2005, 106 (11) : 377A - 377A
[26] Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
Deniger, Drew C.
Switzer, Kirsten
Mi, Tiejuan
Maiti, Sourindra
Hurton, Lenka
Singh, Harjeet
Huls, Helen
Olivares, Simon
Lee, Dean A.
Champlin, Richard E.
Cooper, Laurence J. N.
MOLECULAR THERAPY, 2013, 21 (03) : 638 - 647
[27] PiggyBac, an Efficient Method for Genetic Modification of T Cells with Second Generation CD19-Specific Chimeric Antigen Receptor (CAR) for Treatment of B-Lineage Malignancies
Manuri, Pallavi R.
Maiti, Sourindra N.
Singh, Harjeet
Mi, Tiejuan
Olivares, Simon
Dawson, Margaret J.
Huls, Helen
Lee, Dean A.
Rao, Pulivarthi H.
Kaminski, Joseph M.
Kebriaei, Partow
Wilson, Matthew H.
Cooper, Laurence J. N.
MOLECULAR THERAPY, 2009, 17 : S212 - S213
[28] Fully human CD19-specific chimeric antigen receptors for T-cell therapy
Sommermeyer, D.
Hill, T.
Shamah, S. M.
Salter, A. I.
Chen, Y.
Mohler, K. M.
Riddell, S. R.
LEUKEMIA, 2017, 31 (10) : 2191 - 2199
[29] FIRST CLINICAL TRIALS EMPLOYING SLEEPING BEAUTY SYSTEM AND ARTIFICIAL ANTIGEN PRESENTING CELLS TO GENERATE T CELLS EXPRESSING CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
Kebriaei, P.
Huls, H.
Singh, H.
Olivares, S.
Figliola, M.
Dawson, M.
Jena, B.
Jackson, R.
Bosque, D.
Rondon, G.
McNiece, I.
Hackett, P.
Shpall, E.
Champlin, R.
Cooper, L.
HAEMATOLOGICA, 2013, 98 : 489 - 490
[30] Fully human CD19-specific chimeric antigen receptors for T-cell therapy
D Sommermeyer
T Hill
S M Shamah
A I Salter
Y Chen
K M Mohler
S R Riddell
Leukemia, 2017, 31 : 2191 - 2199

← 1 2 3 4 5 →